“…Some studies have been conducted on treatment recommendations for multimorbidity [12][13][14][15][16][17], while others have focused on specific diseases, including sepsis [18][19][20], oncology [21], non-small-cell lung cancer [8,9], breast cancer [22][23][24], cerebral infarction disease [25], diabetes [26,27], hypertension [28], hypercholesterolemia [29], AIDS [30], adolescent depression [31][32][33][34], bipolar disorder [35,36], anxiety disorders [37], paediatric generalized schizophrenia [38], graft versus host disease [39], thrombosis [40], and paediatric cystic fibrosis [41]. Several works have modelled personalized treatment pathways [42,43], built automatic clinical guidelines [44][45][46], and developed optimized exercise prescription systems [47] for cardiovascular diseases. Few works have been conducted on intelligent learning of dynamic treatment strategies for CHD [48], especially dynamic drug recommendations according to the evolving health status of CHD patients.…”